Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001165527-15-000355
Filing Date
2015-07-22
Accepted
2015-07-22 14:26:16
Documents
1
Period of Report
2015-07-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3607
  Complete submission text file 0001165527-15-000355.txt   5072
Mailing Address 2620 REGATTA DR. STE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DR. STE 102 LAS VEGAS NV 89128 18889709463
Cell Source, Inc. (Issuer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELL SOURCE, INC. 65 YIGAL ALON STREET TEL AVIV L3 67433
Business Address
ZOLTY DAVID (Reporting) CIK: 0001638322 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55413 | Film No.: 15999766